Clinical features and predictors of remission in children under the age of 7 years with Graves’ disease
Abstract Importance Graves’ disease (GD) is rare in children under the age of 7 years. Children with this disease exhibit greater thyrotoxicity at diagnosis and require a longer course of medical therapy, compared with pubertal and postpubertal children and adults. Objective To investigate the clini...
Main Authors: | Yi Gu, Xuejun Liang, Ming Liu, Di Wu, Wenjing Li, Bingyan Cao, Yuchuan Li, Chang Su, Jiajia Chen, Chunxiu Gong |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-09-01
|
Series: | Pediatric Investigation |
Subjects: | |
Online Access: | https://doi.org/10.1002/ped4.12219 |
Similar Items
-
Technetium uptake predicts remission and relapse in Grave's disease patients on antithyroid drugs for at least 1 year in South Indian subjects
by: Neha Singhal, et al.
Published: (2016-01-01) -
Thyroid‐stimulating hormone receptor antibodies during follow‐up as remission markers in childhood‐onset Graves' disease treated with antithyroid drugs
by: Shuo‐Yu Wang, et al.
Published: (2020-04-01) -
Long-Term Antithyroid Drug Treatment of Graves’ Disease in Children and Adolescents: A 20-Year Single-Center Experience
by: Ari Song, et al.
Published: (2021-06-01) -
Graves' Disease: Can It Be Cured?
by: Wilmar M. Wiersinga
Published: (2019-03-01) -
Clinical Phenotypes and Predictors of Remission in Primary Membranous Nephropathy
by: Roxana Jurubiță, et al.
Published: (2021-06-01)